Maria Qureshi is a Cardiology physician. OpenAlex indexes 11 publications with 230 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 N Academy Ave
Danville, PA 178229800
Telephone
570-271-6164Provider last certified this registry record 11 Sept 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year20251 payment
- Chiesi USA, Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.9%Beta blocker24.1%Metoprolol Succinate72%Carvedilol16%Metoprolol Tartrate13%Part D<11 patientsStatin14.8%Atorvastatin Calcium80%Rosuvastatin Calcium20%Part D<11 patients+ 4 more classes in this area
Blood & clotting
22.4%Factor Xa inhibitor11.1%Eliquis100%Part D<11 patientsP2Y12 inhibitor7.3%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.8%Proton pump inhibitor3.5%Pantoprazole Sodium100%Part D<11 patientsSGLT2 inhibitor3.3%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Beyond the heart: a pictorial review of extracardiac findings on cardiac CT
The International Journal of Cardiovascular Imaging
2026 - 26-CCC-18310-ACC MULTIMODALITY IMAGING DIAGNOSIS OF SPONTANEOUS CORONARY ARTERY DISSECTION IN AN ELDERLY FEMALE PRESENTED AS MINOCA
Journal of the American College of Cardiology
2026 - Coronary CT angiography versus invasive angiography for preoperative coronary assessment prior to valve surgery
Journal of cardiovascular computed tomography
2025 - Reply: Balancing innovation and evidence: Coronary computed tomography angiography in preoperative valve surgery
Journal of cardiovascular computed tomography
2025 - Clinical features and outcomes in carriers of pathogenic desmoplakin variants
European Heart Journal
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”